Coronary Artery Disease Therapeutics Market - Business Strategies Studied By Top Key Players Novartis, Pfizer, Bayer, Merck & Co, Glaxo Smith Kline, and Mylan N.V.
Download PDF Brochure of Research Report: https://www.coherentmarketinsights.com/insight/request-pdf/1799
Coronary artery disease can be prevented by maintaining healthy diet, consumption of low fat and low salt fruits and vegetables, physical activity, and management of stress. Treatment of coronary artery disease includes cholesterol modifying medications, ACE inhibitors, Aspirin, beta blockers, Calcium channel blockers, and Ranolazine. Surgeries conducted to treat coronary artery disease include Nitroglycerin, Angioplasty, and coronary artery bypass surgery.
Coronary Artery Disease Therapeutics Market Drivers:-
The global market is expected to witness significant growth due to robust pipeline of drugs over the forecast period (2018-2026). For instance, hydroxychloroquine sulfate tablets sponsored by first affiliated hospital of Xi’an Jiaotong university, China is in the fourth phase of clinical trials, this drug suppresses symptoms of coronary artery disease. Atorvastatin sponsored by university health network, Toronto has completed phase two clinical trials in 2014, this drug reduces the risk of heart attack and myocardial infraction. PADMA 28 sponsored by University hospital Inselsiptal, Berne has completed phase 2 clinical trials in 2013, this drug has beneficial effect on arterial system, the autonomic nervous system and blood inflammatory markers in patients with coronary artery disease.
Furthermore, approval of new drugs for coronary artery disease is another factor driving growth of the coronary artery disease therapeutics market. For instance, in 2016, the U.S. FDA approved Yosprala (Aspirin and Omeprazole) by Aralez Pharmaceuticals, a Canada-based company, this drug is used to prevent cardiovascular diseases. In 2015, FDA approved Repatha by Amgen Inc. This drug is used to treat high cholesterol. In 2015, FDA approved Prestalia by Symplmed Pharmaceuticals LLC, this drug is used to treat hypertension for people suffering with heart disorders. Later in 2017, Prestalia was acquired by Marina Biotech Inc.
Request for Customization of Research Report: https://www.coherentmarketinsights.com/insight/request-customization/1799
Coronary Artery Disease Therapeutics Market Taxonomy:-
The global market is segmented based on drug type, distribution channel and region.
By Drug Type:-
Calcium Channel Blockers
By Distribution Channel:-
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Coherent Market Insights
1001 4th Ave,
Seattle, WA 98154
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Coronary Artery Disease Therapeutics Market - Business Strategies Studied By Top Key Players Novartis, Pfizer, Bayer, Merck & Co, Glaxo Smith Kline, and Mylan N.V. here
News-ID: 1334539 • Views: 530
More Releases from Coherent Market Insights - Clinical Diagnostic Industry
Asia Pacific HIV Diagnostics Market Determined By Market Concentration Rate, New …
HIV diagnostics plays a major role in HIV prevention, treatment, care, and other support services. The diagnosis of HIV includes testing services in health-care facilities, free-standing sites, and a wide range of community-based approaches along with HIV self-testing. Developments such as home testing represent new and major opportunities for addressing HIV among men who have sex with men (MSM). According to the UNAIDS, the Joint United Nations Program on HIV
Precision Medicine Diagnostics Market Innovative Treatments, Key Methodologies, …
Precision medicine aims to alter the treatments based on individual characteristics, including differences in genetics, environment, and lifestyle. It has the potential to transform the delivery of care for a variety of diseases. Precision medicine implicate the application of panomic analysis and systems biology to inspect the cause of an individual patient's diseased condition at the molecular level and then to apply targeted treatments to address that individual patient's disease.
Influenza Diagnostics Market: Healthcare Industry to Remain Key End-use; Vital A …
Global Influenza Diagnostics Market, by Test Type (Traditional Diagnostic Test and Molecular Diagnostic Assays), by End User (Hospitals and Clinics, Reference Laboratories, and Others), and by Geography (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018- 2026 Download PDF Brochure Of This Research Report @ https://www.coherentmarketinsights.com/insight/request-pdf/2414 Influenza (flu) is a contagious disease of the upper respiratory system caused due to
Constipation Treatment Market Insights With Key Players AstraZeneca, Takeda Phar …
Constipation Treatment Market Overview Constipation is a disorder that causes issues related to clearing of the bowels and usually leads to hardened feces. It is especially prevalent among the elderly and women. Common symptoms of constipation include lumpy or hard stools, lower abdominal discomfort, straining to have bowel movements, feeling of blockage in rectum that prevents bowel movements, and infrequent bowel movements. Factor that can lead to constipation are aging, dehydration,
More Releases for Coronary
Coronary Microcatheters Market 2021 | Detailed Report
The Coronary Microcatheters research report provides a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The data thus presented is reliable, comprehensive and the result of extensive research both primary and secondary. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. Moreover, the data underlines the primary and secondary drivers,
Intravascular Ultrasound Systems Market(By Product Type - Ivus Consoles, Ivus Ca …
Intravascular Ultrasound Systems (IVUS) is an imaging method with which we can visualize a coronary artery from the inside out. Intravascular Ultrasound Systems are usually designed in such a way that the individual can have a complete view of the coronary artery blockade using a catheter which is attached to an ultrasound probe at one end and the other end is attached to a computerized ultrasound equipment. The inside out view
Coronary Stents Market - Competitive Strategies 2025
Global Coronary Stents Market: Snapshot The market for coronary stents has been gaining significant traction across the world. Technological advancements, increasing burden of CAD, and the rising base of geriatric population are the main factors that have been fueling the demand for coronary stents substantially. Apart from these, the augmenting demand for minimally invasive procedures and the rising number of percutaneous coronary intervention (PCI) procedures are also supplementing to the growth
Global Coronary Stents Market 2018
Press Release - 28 Feb 2018 Global Research and Development News -- . . Report Description- '
Coronary Stents Market Is Thriving Worldwide
HTF MI published a new industry research that focuses on Coronary Stents market and delivers in-depth market analysis and future prospects of Global Coronary Stents market. The study covers significant data which makes the research document a handy resource for managers, analysts, industry experts and other key people get ready-to-access and self-analyzed study along with graphs and tables to help understand market trends, drivers and market challenges. The study is
Coronary Stent Market Ongoing Outlook 2025
Global Coronary Stent Market: Overview The alarming rise in the number of cardiovascular diseases has become the primary growth driver for the global coronary stent market. Changing lifestyles that are characterized by high stress levels, alcohol consumption, smoking, and poor choice of food habits have collectively led to questionable heart health for the global market. The World Health Organization states that the cardiovascular diseases have become the leading cause of deaths